查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930074

全球血型鑑定市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析、未来预测（2026-2034）

Blood Group Typing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 177 Pages | 商品交期: 请询问到货日

价格

血型鑑定市场成长驱动因子

全球血型鑑定市场在现代医学中发挥至关重要的作用，为输血、器官移植、创伤救治和产前检测提供支援。根据 Fortune Business Insights 预测，该市场预计在 2025 年达到 23.1 亿美元，并从 2026 年的 25.2 亿美元增长到 2034 年的 52.7 亿美元，2026 年至 2034 年的复合年增长率 (CAGR) 为 9.60%。这一强劲的成长动能主要得益于全球捐血量的增加、创伤病例的增加以及移植手术的普及。

市场动态与流行病学因素

血型鑑定在急诊和外科手术中至关重要，因为它能确定捐血者和受血者的血型是否相容。意外事故和创伤病例的增加显着提高了对大量输血的需求。研究表明，十分之六的创伤相关死亡发生在最初3小时内，原因是出血过多，凸显了快速血型鑑定的重要性。

此外，世界卫生组织（WHO）报告称，2008年至2018年间，自愿捐血量增加了1070万，直接促使血型鑑定数量的增加。慢性疾病负担的加重、外科手术的增加以及产前筛检计画的扩展也进一步推动了市场扩张。

新冠疫情对市场的影响

由于捐血量减少、供应链中断以及就诊量下降，新冠疫情暂时扰乱了血型鑑定市场。 2020财年，包括Bio-Rad Laboratories在内的多家大型公司报告称，其临床诊断业务收入下降了7.6%。然而，在患者就诊量改善和自动化血型鑑定技术加速普及的推动下，预计该市场将在2021年和2022年復苏，恢復成长动能。 主要市场趋势 影响市场的关键趋势是自动化血型鑑定技术的应用，包括基于PCR和微阵列的系统。这些技术提高了检测准确性，减少了人为误差，并缓解了熟练医务人员短缺的问题。例如，2020年7月，日本东京理科大学的科学家开发出一种晶片实验室设备，能够在五分钟内确定血型，并取得了技术突破。

市场区隔分析

依产品类型划分，试剂和试剂盒将主导市场，到 2026 年将占 80.43% 的市场占有率，这主要得益于它们在输血和捐血过程中的广泛应用。随着自动化技术的进步，仪器的市场占有率预计将稳定成长。

依检测类型划分，抗体筛检将在 2026 年占市场主导地位，市占率为 39.80%，这主要得益于产前检测的兴起和慢性病盛行率的上升。其次是 ABO 血型检测，器官移植的增加推动了对 HLA 分型和交叉配对的需求。

依技术划分，血清学检测将在 2026 年占最大市场占有率，达到 59.42%，这主要得益于其操作简便和广泛应用。分子检测由于能够检测弱抗原变异体并提高输血安全性，预计将成长更快。

依最终用户划分，独立实验室和血库将在2026年占59.42%的市场占有率，这主要得益于检测网路的扩展，尤其是在新兴经济体。

区域洞察

北美地区凭藉强有力的报销政策和对输血的高需求，将以34.70%的市场占有率引领全球市场，预计到2025年市场规模将达到8亿美元。美国市场预计到2026年将达到8.1亿美元。

欧洲则位居第二，主要得益于输血量的成长和政府主导的器官捐赠计画。

由于研发投入增加，亚太地区预计将实现强劲成长，其中中国、日本和印度预计到2026年将显着扩张。

拉丁美洲以及中东和非洲是新兴市场，这得益于医疗基础设施的改善和捐血意识的提高。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 血型鑑定技术的最新进展
  • 主要国家的捐血量
  • 主要国家和地区的输血量
  • 产业关键趋势：併购、商业联盟
  • HLA分型产品领域其他公司概览
  • HLA分型价格分析产品
  • 新冠疫情对血型鑑定市场的影响

第五章：全球血型鑑定市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品分类
    • 仪器
    • 试剂和试剂盒
  • 市场分析、洞察与预测：依检测类型
    • ABO血型检测
    • 抗原分型
    • 抗体筛检
    • 交叉配血试验
    • HLA分型
  • 市场分析、洞察与预测：依技术分类
    • 血清学检测
    • 分子检测
  • 市场分析、洞察与预测：依最终用户分类
    • 医院实验室
    • 独立实验室、血库
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美血型鑑定市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲血型鑑定市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区血型鑑定市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲血型鑑定市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

章节10：中东与非洲血型鑑定市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC) 国家
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 世界市场占有率分析(2025年)
  • 企业简介
    • Quotient Limited
    • CareDx Inc.
    • Agena Bioscience, Inc.(Mesa Laboratories, Inc.)
    • DIAGAST
    • Illumina, Inc.
    • Grifols, S.A.
    • Immucor, Inc.
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • QIAGEN
    • Beckman Coulter, Inc.(Danaher)
    • QuidelOrtho Corporation
Product Code: FBI101767

Growth Factors of blood group typing Market

The global blood group typing market plays a critical role in modern healthcare, supporting blood transfusions, organ transplantation, trauma care, and prenatal testing. According to Fortunebusinessinsights, the market was valued at USD 2.31 billion in 2025 and is projected to grow from USD 2.52 billion in 2026 to USD 5.27 billion by 2034, registering a CAGR of 9.60% during 2026-2034. The strong growth trajectory is driven by rising blood donations, increasing trauma cases, and expanding transplantation procedures worldwide.

Market Dynamics and Epidemiological Drivers

Blood group typing determines compatibility between donors and recipients, making it indispensable in emergency medicine and surgical care. The rising incidence of accidents and trauma cases has significantly increased the need for massive blood transfusions. Studies indicate that 6 out of 10 trauma-related deaths occur within the first three hours due to excessive bleeding, highlighting the critical role of timely blood typing.

Additionally, the World Health Organization (WHO) reported a rise of 10.7 million voluntary blood donations between 2008 and 2018, directly increasing the volume of blood group typing procedures. The growing burden of chronic diseases, rising surgical volumes, and expanding prenatal screening programs further support market expansion.

Market Impact of COVID-19

The COVID-19 pandemic temporarily disrupted the blood group typing market due to reduced blood donations, supply chain interruptions, and fewer hospital visits. In FY 2020, key players such as Bio-Rad Laboratories, Inc. reported a 7.6% decline in revenues from clinical diagnostics segments. However, market recovery was observed in 2021 and 2022, supported by improved patient inflow and accelerated adoption of automated blood typing technologies, restoring the market's growth momentum.

Key Market Trends

A major trend shaping the market is the adoption of automated blood group typing technologies, including PCR-based and microarray systems. These technologies improve testing accuracy, reduce human errors, and address shortages of skilled healthcare professionals. For example, in July 2020, scientists from Tokyo University of Science, Japan, developed a lab-on-a-chip device capable of determining blood type within five minutes, marking a significant technological advancement.

Market Segmentation Analysis

By Product, reagents and kits dominated the market, accounting for 80.43% share in 2026, due to their extensive use in transfusion and donation procedures. Instruments are expected to grow steadily with increased automation.

By Test Type, antibody screening led the market with a 39.80% share in 2026, driven by growing prenatal testing and chronic disease prevalence. ABO testing followed, while HLA typing and cross-matching tests are gaining traction due to rising organ transplantation procedures.

By Technique, serology tests held the largest share at 59.42% in 2026, owing to ease of use and widespread availability. Molecular tests are projected to grow faster due to their ability to detect weak antigen variants and improve transfusion safety.

By End User, independent laboratories and blood banks dominated with a 59.42% share in 2026, supported by expanding laboratory networks, particularly in emerging economies.

Regional Insights

North America dominated the global market with a 34.70% share in 2025, reaching USD 0.8 billion, driven by strong reimbursement policies and high transfusion demand. The U.S. market is projected to reach USD 0.81 billion by 2026.

Europe ranked second, supported by increasing transfusion volumes and government-led organ donation initiatives.

Asia Pacific is expected to witness strong growth due to rising R&D investments, with China, Japan, and India showing notable expansion by 2026.

Latin America and the Middle East & Africa are emerging markets, supported by improving healthcare infrastructure and growing awareness of blood donations.

Competitive Landscape

The market is semi-consolidated, led by QuidelOrtho Corporation, followed by Grifols S.A. and Bio-Rad Laboratories, Inc. These players focus on product innovation, strategic partnerships, and geographic expansion. Recent launches such as automated analyzers and next-generation HLA typing tests continue to strengthen competition.

Conclusion

In conclusion, the global blood group typing market is set for robust growth from USD 2.31 billion in 2025 to USD 5.27 billion by 2034, driven by increasing blood donations, trauma cases, and transplantation procedures. Technological advancements, especially in automated and molecular testing, are transforming diagnostic efficiency and safety. While infrastructure gaps in emerging countries remain a challenge, sustained government initiatives and private-sector innovation are expected to strengthen market penetration. Overall, the market presents strong long-term growth opportunities across both developed and developing regions.

Segmentation By Product

  • Instruments
  • Reagents & Kits

By Test Type

  • ABO Tests
  • Antigen Typing
  • Antibody Screening
  • Cross-matching Tests
  • HLA Typing

By Technique

  • Serology Tests
  • Molecular Tests

By End-user

  • Hospital-based Laboratories
  • Independent Laboratories & Blood Banks

By Region

  • North America (By Product, By Test Type, By Technique, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Blood Group Typing Techniques
  • 4.2. Number of Blood Donations, For Key Countries
  • 4.3. Number of Blood Transfusions, For Key Countries/ Region
  • 4.4. Key Industry Developments: Mergers, Partnership, Acquisitions
  • 4.5. Brief Overview of Other Companies Operating in HLA Typing Products
  • 4.6. Pricing Analysis of HLA Typing Products
  • 4.7. Impact of COVID-19 on Blood Group Typing Market

5. Global Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Instruments
    • 5.1.2. Reagents & Kits
  • 5.2. Market Analysis, Insights and Forecast - By Test Type
    • 5.2.1. ABO Tests
    • 5.2.2. Antigen Typing
    • 5.2.3. Antibody Screening
    • 5.2.4. Cross-matching Tests
    • 5.2.5. HLA Typing
  • 5.3. Market Analysis, Insights and Forecast - By Techniques
    • 5.3.1. Serology Tests
    • 5.3.2. Molecular Tests
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospital-based Laboratories
    • 5.4.2. Independent Laboratories & Blood Banks
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Instruments
    • 6.1.2. Reagents & Kits
  • 6.2. Market Analysis, Insights and Forecast - By Test Type
    • 6.2.1. ABO Tests
    • 6.2.2. Antigen Typing
    • 6.2.3. Antibody Screening
    • 6.2.4. Cross-matching Tests
    • 6.2.5. HLA Typing
  • 6.3. Market Analysis, Insights and Forecast - By Techniques
    • 6.3.1. Serology Tests
    • 6.3.2. Molecular Tests
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospital-based Laboratories
    • 6.4.2. Independent Laboratories & Blood Banks
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Instruments
    • 7.1.2. Reagents & Kits
  • 7.2. Market Analysis, Insights and Forecast - By Test Type
    • 7.2.1. ABO Tests
    • 7.2.2. Antigen Typing
    • 7.2.3. Antibody Screening
    • 7.2.4. Cross-matching Tests
    • 7.2.5. HLA Typing
  • 7.3. Market Analysis, Insights and Forecast - By Techniques
    • 7.3.1. Serology Tests
    • 7.3.2. Molecular Tests
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospital-based Laboratories
    • 7.4.2. Independent Laboratories & Blood Banks
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Instruments
    • 8.1.2. Reagents & Kits
  • 8.2. Market Analysis, Insights and Forecast - By Test Type
    • 8.2.1. ABO Tests
    • 8.2.2. Antigen Typing
    • 8.2.3. Antibody Screening
    • 8.2.4. Cross-matching Tests
    • 8.2.5. HLA Typing
  • 8.3. Market Analysis, Insights and Forecast - By Techniques
    • 8.3.1. Serology Tests
    • 8.3.2. Molecular Tests
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospital-based Laboratories
    • 8.4.2. Independent Laboratories & Blood Banks
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Instruments
    • 9.1.2. Reagents & Kits
  • 9.2. Market Analysis, Insights and Forecast - By Test Type
    • 9.2.1. ABO Tests
    • 9.2.2. Antigen Typing
    • 9.2.3. Antibody Screening
    • 9.2.4. Cross-matching Tests
    • 9.2.5. HLA Typing
  • 9.3. Market Analysis, Insights and Forecast - By Techniques
    • 9.3.1. Serology Tests
    • 9.3.2. Molecular Tests
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospital-based Laboratories
    • 9.4.2. Independent Laboratories & Blood Banks
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Instruments
    • 10.1.2. Reagents & Kits
  • 10.2. Market Analysis, Insights and Forecast - By Test Type
    • 10.2.1. ABO Tests
    • 10.2.2. Antigen Typing
    • 10.2.3. Antibody Screening
    • 10.2.4. Cross-matching Tests
    • 10.2.5. HLA Typing
  • 10.3. Market Analysis, Insights and Forecast - By Techniques
    • 10.3.1. Serology Tests
    • 10.3.2. Molecular Tests
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospital-based Laboratories
    • 10.4.2. Independent Laboratories & Blood Banks
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Quotient Limited
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. CareDx Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Agena Bioscience, Inc. (Mesa Laboratories, Inc.)
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. DIAGAST
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Illumina, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Grifols, S.A.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Immucor, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Bio-Rad Laboratories, Inc.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Thermo Fisher Scientific Inc.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Merck KGaA
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. QIAGEN
      • 11.2.11.1. Overview
      • 11.2.11.2. Products & Services
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)
    • 11.2.12. Beckman Coulter, Inc. (Danaher)
      • 11.2.12.1. Overview
      • 11.2.12.2. Products & Services
      • 11.2.12.3. SWOT Analysis
      • 11.2.12.4. Recent Developments
      • 11.2.12.5. Strategies
      • 11.2.12.6. Financials (Based on Availability)
    • 11.2.13. QuidelOrtho Corporation
      • 11.2.13.1. Overview
      • 11.2.13.2. Products & Services
      • 11.2.13.3. SWOT Analysis
      • 11.2.13.4. Recent Developments
      • 11.2.13.5. Strategies
      • 11.2.13.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 02: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 03: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 04: Global Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 05: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 06: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 07: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 08: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 09: North America Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 10: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 12: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 13: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 14: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 15: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 16: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 17: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 18: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 19: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 20: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 21: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 22: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 23: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 24: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 25: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 26: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 27: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 28: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 29: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 30: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

List of Figures

  • Figure 01: Global Blood Group Typing Market Value Share (%), By Product, 2025 & 2034
  • Figure 02: Global Blood Group Typing Market Value Share (%), By Test Type, 2025 & 2034
  • Figure 03: Global Blood Group Typing Market Value Share (%), By Techniques, 2025 & 2034
  • Figure 04: Global Blood Group Typing Market Value Share (%), By End User, 2025 & 2034
  • Figure 05: Global Blood Group Typing Market Value Share (%), By Region, 2025 & 2034
  • Figure 06: North America Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
  • Figure 07: North America Blood Group Typing Market Value Share (%), By Product, 2025
  • Figure 08: North America Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
  • Figure 09: North America Blood Group Typing Market Value Share (%), By Test Type, 2025
  • Figure 10: North America Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
  • Figure 11: North America Blood Group Typing Market Value Share (%), By Techniques, 2025
  • Figure 12: North America Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 13: North America Blood Group Typing Market Value Share (%), By End User, 2025
  • Figure 14: North America Blood Group Typing Market Value (USD billion), By Country, 2025 & 2034
  • Figure 15: North America Blood Group Typing Market Value Share (%), By Country, 2025
  • Figure 16: Europe Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
  • Figure 17: Europe Blood Group Typing Market Value Share (%), By Product, 2025
  • Figure 18: Europe Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
  • Figure 19: Europe Blood Group Typing Market Value Share (%), By Test Type, 2025
  • Figure 20: Europe Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
  • Figure 21: Europe Blood Group Typing Market Value Share (%), By Techniques, 2025
  • Figure 22: Europe Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 23: Europe Blood Group Typing Market Value Share (%), By End User, 2025
  • Figure 24: Europe Blood Group Typing Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 25: Europe Blood Group Typing Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 26: Asia Pacific Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
  • Figure 27: Asia Pacific Blood Group Typing Market Value Share (%), By Product, 2025
  • Figure 28: Asia Pacific Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
  • Figure 29: Asia Pacific Blood Group Typing Market Value Share (%), By Test Type, 2025
  • Figure 30: Asia Pacific Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
  • Figure 31: Asia Pacific Blood Group Typing Market Value Share (%), By Techniques, 2025
  • Figure 32: Asia Pacific Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 33: Asia Pacific Blood Group Typing Market Value Share (%), By End User, 2025
  • Figure 34: Asia Pacific Blood Group Typing Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 35: Asia Pacific Blood Group Typing Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 36: Latin America Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
  • Figure 37: Latin America Blood Group Typing Market Value Share (%), By Product, 2025
  • Figure 38: Latin America Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
  • Figure 39: Latin America Blood Group Typing Market Value Share (%), By Test Type, 2025
  • Figure 40: Latin America Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
  • Figure 41: Latin America Blood Group Typing Market Value Share (%), By Techniques, 2025
  • Figure 42: Latin America Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 43: Latin America Blood Group Typing Market Value Share (%), By End User, 2025
  • Figure 44: Latin America Blood Group Typing Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 45: Latin America Blood Group Typing Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 46: Middle East & Africa Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
  • Figure 47: Middle East & Africa Blood Group Typing Market Value Share (%), By Product, 2025
  • Figure 48: Middle East & Africa Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
  • Figure 49: Middle East & Africa Blood Group Typing Market Value Share (%), By Test Type, 2025
  • Figure 50: Middle East & Africa Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
  • Figure 51: Middle East & Africa Blood Group Typing Market Value Share (%), By Techniques, 2025
  • Figure 52: Middle East & Africa Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 53: Middle East & Africa Blood Group Typing Market Value Share (%), By End User, 2025
  • Figure 54: Middle East & Africa Blood Group Typing Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 55: Middle East & Africa Blood Group Typing Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 56: Global Blood Group Typing Market Share (%), By Company, 2025